Showing results (71-80 of 173) with videos related to
Sort By:
Pageof 18
Lipids in Health and Disease|March 24, 2016
The relationship between omega-3 and smoking habit: a cross-sectional studyNóris Scaglia, José Chatkin, Kenneth R Chapman, et al.Journal of Breath Research|March 28, 2012
Profile of eicosanoids in breath condensate in asthma and COPDLeandro Genehr Fritscher, Martin Post, Marcelo Tadday Rodrigues, et al.American Journal of Respiratory and Critical Care Medicine|January 4, 2014
Minimal clinically important differences in pharmacological trialsPaul W Jones, Kai M Beeh, Kenneth R Chapman, et al.Anesthesiology|August 15, 2012
A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trialJean Wong, Amir Abrishami, Yiliang Yang, et al.International Journal of Chronic Obstructive Pulmonary Disease|March 29, 2021
The Impact of Exacerbation History on the Safety and Efficacy of Aclidinium in Patients with Chronic Obstructive Pulmonary Disease and Increased Cardiovascular Risk: ASCENT-COPD TrialRobert A Wise, Kenneth R Chapman, Benjamin M Scirica, et al.The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 29, 2019
Usability of mepolizumab single-use prefilled autoinjector for patient self-administrationDavid Bernstein, Ian D Pavord, Kenneth R Chapman, et al.Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|February 4, 2024
Real-world outcomes of mepolizumab for the treatment of severe eosinophilic asthma in Canada: an observational studyKenneth R Chapman, Kathryn Cogger, Erin Arthurs, et al.International Journal of Chronic Obstructive Pulmonary Disease|July 16, 2011
Delivery characteristics and patients' handling of two single-dose dry-powder inhalers used in COPDKenneth R Chapman, Charles M Fogarty, Clare Peckitt, et al.International Journal of Chronic Obstructive Pulmonary Disease|February 6, 2019
Real-life effectiveness of indacaterol-glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER studyAlan Kaplan, Kenneth R Chapman, Syed M Anees, et al.Chest|September 11, 2010
Nontuberculous mycobacterial infection as a cause of difficult-to-control asthma: a case-control studyLeandro G Fritscher, Theodore K Marras, Ana C Bradi, et al.Pageof 18